Related Articles
Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cells
Paclitaxel combined with cis-platin as second-line treatment in patients with advanced non-small cell lung cancers refractory to cis-platin.
A NEW DERIVATIVE OF CAMPTOTHECIN, IRINOTECAN HYDROCHLORIDE (CPT-11) INDUCES PROGRAMMED CELL-DEATH IN LEUKEMIA-LYMPHOMA CELL-LINES
Sensitivity to chemotherapeutics of NSCLC cells with acquired resistance to EGFR-TKIs is mediated by T790M mutation or epithelial-mesenchymal transition
Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: Induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms